Veriheal

NOVEMBER 17, 2020

Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523. Strict Guidelines Must be Met Before Conditions Will Be Considered.

Conditions 98

Conditions Research and Development Pharmaceutical Clinical Trials 98

Project CBD

MARCH 21, 2023

She was upset with herself for being so careless and concerned that the condition would persist. For many other people of all ages, tinnitus is indeed a chronic condition that has nothing to do with loud ‘80s cover bands in small clubs. And it’s not just ringing.

Cannabinoids 144

Cannabinoids Clinical Trials Sleep Blood Pressure 144

Cannabis Law Report

AUGUST 22, 2021

Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Presently, the company is working with researchers to build out these technologies and pave the way for clinical trials. Silo Pharma Inc. Looking to the Future. Silo Pharma Inc.

Clinical Trials 105

Clinical Trials Research and Development Safety Treatment 105

NewsMunchies

DECEMBER 13, 2021

In the largest clinical trial to date, a new study conducted by the UK-based pharmaceutical company Compass Pathways shows that psilocybin or “magic” mushrooms can safely relieve depression. The trial included 233 patients from 10 countries in North America and Europe. In 2019, Denver became the first city in the U.S.

Clinical Trials 95

Clinical Trials Therapy Decriminalization Patients 95

CannaMD

APRIL 23, 2020

Michael Farley , the President and Director of GBS Global Biopharma, the Canadian wing of GB Sciences, spoke to the study’s implications for the future: We look forward to bringing these promising formulations into human clinical trials as early as 2020. FDA in order to enter human clinical trial as early as this year!

Clinical Trials 116

Clinical Trials Research and Development Marijuana Treatment 116

The Cannigma

MARCH 18, 2021

The study was compiled by way of an anonymous email survey sent to 7,607 people with Parkinson’s disease in January 2020. An overwhelming 84.7% said that cannabis use had no impact on prescription medication usage, and 89% said they had not thought that cannabis would replace their prescription medications for Parkinson’s Disease.

Patients 145

Patients Clinical Trials Treatment Cannabis 145

The Cannigma

MAY 19, 2021

This was notoriously reflected in the 2020 arrest of a Japanese man and woman for speaking positively about using cannabis in social media posts. Japan does not have a medical cannabis program and does not allow the use of cannabis for patients seeking to treat a medical condition. The future of weed legalization in Japan.

Law 145

Law Legalization Clinical Trials CBD 145

Puff Puff Post

MARCH 10, 2020

“We are very pleased with the rapid completion of enrollment achieved by the team at the Centre for Human Drug Research (CHDR) in Leiden, the Netherlands,” said Alexandra Mancini, InMed’s Senior Vice President of Clinical Development & Regulatory Affairs. SOURCE InMed Pharmaceuticals Inc.

Clinical Trials 40

Clinical Trials Pharmaceutical Research and Development Cannabinoids 40

Cannabis Law Report

DECEMBER 2, 2021

(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.

Clinical Trials 40

Clinical Trials Data Patients THC 40

CannaMD

JUNE 2, 2021

In a paper presented at the 2020 International Congress of Parkinson’s Disease and Movement Disorders , the authors reported on the results of an anonymous survey completed by more than 1,000 individuals living with Parkinson’s disease. Florida is among these states.

Patients 105

Patients Clinical Trials Treatment Research and Development 105

Veriheal

JULY 16, 2020

Following months of meetings, the Creating Options for Veterans Expedited Recovery ( COVER ) Commission released its report in January 2020. federal government’s policies have blocked externally valid, randomized clinical trials on the effects of cannabis,” the report says. Veterans across the U.S.

Research and Development 97

Research and Development Clinical Trials Treatment Compliance 97

Cannabis Law Report

AUGUST 25, 2021

“Lucid has successfully developed a strong pipeline of novel therapeutic compounds — supported by IP in order to advance to future clinical trials — and we are confident that the experience the Lucid leadership team brings will allow us to immediately start the process towards clinical trials to further advance these promising therapies.

Clinical Trials 85

Clinical Trials Research and Development Therapy Conditions 85

Cannabis Law Report

SEPTEMBER 1, 2021

Going public in November 2020 on the NEO exchange, the firm has been steadily growing its market cap and development pipeline. The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. Field Trip Health Ltd.

Research and Development 102

Research and Development Clinical Trials Therapy Pharmaceutical 102

CannaMD

SEPTEMBER 9, 2020

Published only recently, in May of 2020, this clinical trial is the first to show that microdoses of cannabis can be just as effective as much higher doses. In fact, the very best dose of cannabis might be the dose you don’t immediately feel at all! Before getting into the study itself, though, let’s go over the basics.

Microdosing 111

Microdosing Marijuana Clinical Trials Chronic Pain 111

Veriheal

APRIL 18, 2022

Unfortunately, research on cannabis and aging remains limited but its benefits for aging can be seen through existing research on medical conditions associated with getting older. Many of these chronic conditions can benefit from medicinal cannabis, which supports the use of cannabis for aging. .

Research and Development 98

Research and Development Clinical Trials Conditions Cannabis 98

Cannabis Law Report

JULY 9, 2021

On November 3, 2020, Oregon became the first state to decriminalize psilocybin for recreational purposes. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way. Id ; 21 CFR 312.1-10;

Law 81

Law Therapy Clinical Trials Research and Development 81

Cannabis Law Report

FEBRUARY 1, 2022

Bod Australia has announced its planned phase IIB clinical trial of a cannabis extract with insomnia patients has received ethics approval. The trial will investigate the efficacy of a new prospective Schedule 3 CBD (cannabidiol) formulation on insomnia symptoms.

Clinical Trials 59

Clinical Trials CBD Medicine Extraction 59

Project CBD

FEBRUARY 28, 2023

This was somewhat less than the nearly 37% decline seen in 2020. decline from 2020. Despite the companies’ submitting the required data demonstrating the “reasonable expectation of safety under the recommended conditions of use,” the FDA rejected the applications, citing the drug preclusion clause. million on these products.

CBD 144

CBD Seed-To-Sale Food Access 144

LifeCannMD

MAY 27, 2025

Florida recognizes epilepsy as a qualifying condition, so you don’t need to prove that everything else failed first. A terminal condition diagnosed by a physician other than the qualified physician issuing the physician certification. Epilepsy is actually a qualifying condition for Medical Marijuana in the State of Florida.

CBD 52

CBD Oil Epilepsy Sleep 52

Cannabis Law Report

FEBRUARY 24, 2022

Subsection 56(1) of the CDSA will exempt medical providers from enforcement of the CDSA when providing psilocybin and MDMA treatment to patients suffering serious or terminal health conditions. In 2020, Health Canada published a Notice of Intent alerting the medical community of the plan to reopen SAP to restricted drugs.

Therapy 52

Therapy Access Clinical Trials Treatment 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. North America was the largest regional market in 2020 owing to high demand and positive attitude toward cannabis.

Recreational 73

Recreational Hemp THC Legalization 73

Cannabis Law Report

MAY 10, 2022

Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows. Since the beginning of the program, medicinal cannabis has been prescribed for over 140 conditions.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

DECEMBER 14, 2019

In October, some Canadian firms adjusted their global expansion plans in Australia due to the conditions seen in the cannabis industry. Clinical stage CBD company Botanix Pharmaceuticals (ASX: BDA ) works on using cannabidiol (CBD) in its treatment of skin conditions including acne, psoriasis, dermatitis and rosacea.

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. In 2020, based on application, the others segment accounted for the largest revenue share.

Cannabinoids 40

Cannabinoids Clinical Trials Research and Development Supply Chain 40

Cannabis Law Report

MAY 10, 2022

More than half of all prescriptions for medicinal cannabis in Australia are written by doctors in Queensland, with prescriptions often given for conditions there is little evidence medicinal cannabis can treat, new research reveals. After 2020, those between 20 and 31 years old were the predominant group being prescribed medicinal cannabis.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Cannabis Law Report

DECEMBER 23, 2021

The use of cannabinoids in the treatment of medical conditions offers major opportunities, but also challenges to anyone operating in the space. Epidiolex is currently the poster child for a successful cannabinoid pharmaceutical; garnering over €430 million in sales in 2020 and serving an estimated patient population of more than 20,000.

Pharmaceutical 74

Pharmaceutical Clinical Trials Research and Development Cannabinoids 74

LifeCannMD

MAY 27, 2025

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. A 2022 meta-analysis of 23 studies published in Clinical Pharmacology & Therapeutics found that therapeutic effects plateau at relatively low doses for most conditions.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

The Cannigma

OCTOBER 14, 2022

In 2019 the Parliament approved a citizen’s proposal to regulate recreational use of cannabis, but backtracked in March 2020 , saying they would wait to follow the lead of Italy. San Marino is a mountainous microstate that is enclosed by Italy on all sides. San Marino medical marijuana program. Is CBD legal in San Marino?

Law 56

Law Clinical Trials Research and Development Recreational 56

The Cannigma

JUNE 24, 2021

While many health conditions can be treated with more traditional pharmaceuticals, plant-based products may be a safer and healthier option – or at least a safe health supplement. By interacting with the receptors of the ECS, cannabis modulates the bodily functions that cause or exacerbate health conditions.

CBD 105

CBD Microdosing Edibles Sleep 105

Cannabis Law Report

OCTOBER 13, 2021

Continued innovation, as demonstrated by our expanding IP portfolio, positions Cybin as a leading innovator in the development of putative psychedelic treatments for a variety of mental health conditions,” said Doug Drysdale, the company’s CEO. Vigorous scientific research and clinical trials are needed. About Cybin.

Clinical Trials 52

Clinical Trials Research and Development Treatment Conditions 52

Cannabis Law Report

MARCH 22, 2020

9:46 AM – Mar 19, 2020. The questionnaire asks a patient’s symptoms, if they are concerned about contracting COVID-19, what conditions they are currently treating with medical cannabis or other pharmaceuticals and how effective they feel those treatments to be. Twitter Ads info and privacy. 7,739 people are talking about this.

THC 59

THC Clinical Trials Data Consumption 59

Healer

DECEMBER 17, 2021

Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . The Journal of Clinical Pharmacology 60.4

CBD 98

CBD THC Conditions Medicine 98

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? For a drug to be approved by the FDA, it must go through Phase 1, 2, and 3 clinical trials.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

Cannabis Law Report

NOVEMBER 12, 2021

Completed manufacturing of ANEB-001 capsules for upcoming Phase 2 clinical trial. On track to commence Phase 2 proof-of-concept clinical trial with ANEB-001 for the treatment of acute cannabinoid intoxication by year-end. The founding co-chairs are Andrew Monte, M.D., and Arjun Chanmugam, M.D., September 30, 2021. . .

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

CannaMD

AUGUST 26, 2020

Note: No human studies were found (with the exception of one clinical trial that was ongoing and therefore not selected); all studies focused on animals (i.e., Conditioned place preference. In 2020, researchers demonstrated that CBD was able to block cocaine-enhanced brain-stimulation reward. mice/rats). But not to worry.

Therapy 98

Therapy CBD Research and Development Treatment 98

Cannabis Law Report

DECEMBER 21, 2021

Within a few months, it had completed the first phase of its clinical trial of DMT in combination with supportive psychotherapy and commenced a phase 2a trial. In 2021 it filed several additional patent applications while conducting head-to-head studies on its lead clinical candidate, MSP-1014.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

OCTOBER 4, 2021

A multitude of recent clinical trials shows the clear promise of psilocybin for this population suffering from these debilitating conditions. Oregon’s Psilocybin Services Act (“PSA”), adopted via initiative in November 2020, makes therapeutic use of psilocybin legal under Oregon state law. Conclusion.

Therapy 52

Therapy Patients Law Clinical Trials 52